Thomas Lynch

Thomas Lynch

Director/Board Member at FOGHORN THERAPEUTICS INC.

Net worth: 517 112 $ as of 2026-06-29

65 year
Health Services
Commercial Services
Health Technology

Profile

Thomas James Lynch is President & Director at Fred Hutchinson Cancer Research Center since 2020.
Dr. Lynch is President & Director at Fred Hutchinson Cancer Center since 2020.
Dr. Lynch is Director at The Schwartz Center for Compassionate Healthcare since 2014.
Dr. Lynch is Independent Director at Foghorn Therapeutics, Inc. since 2022.
Dr. Lynch is Non-Executive Director at Hummingbird Bioscience Pte Ltd. since 2021.
Dr. Lynch is Independent Director at Natera, Inc. since 2026.
Dr. Lynch is a Member of the American Society of Clinical Oncology, Inc., International Association for the Study of Lung Cancer, Washington State Academy of Sciences, and American Association for Cancer Research.
Former roles include Chairman & Chief Executive Officer at Massachusetts General Physician's Organization, Inc. from 2015 to 2017.
Chairman at Kleo Pharmaceuticals, Inc. from 2019 to 2020.
Independent Director at Infinity Pharmaceuticals, Inc. from 2012 to 2014.
Director & Professor at Yale Cancer Center from 2009 to 2015.
Director at The Massachusetts General Hospital from 2015 to 2017.
Director at PearlPoint Cancer Support, Inc. Chief Scientific Officer & Executive VP at Bristol Myers Squibb Co. from 2017 to 2019.
Chief-Oncology Hematology at The General Hospital Corp.
from 2007 to 2009.
Professor-Medicine at Harvard Medical School from 2008 to 2009.
Professor at Yale School of Medicine from 2009 to 2015.
Education includes a doctorate from Yale University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-25 1,905 ( 0% ) 517 112 $ 2026-06-29
2026-06-23 0 ( -.--% ) - $ 2026-06-29

Thomas Lynch active positions

CompaniesPositionStart
FOGHORN THERAPEUTICS INC. Director/Board Member 2022-10-26
NATERA, INC. Director/Board Member 2026-06-02
Corporate Officer/Principal -
Director/Board Member 2021-07-25
President 2019-12-31
President 2020-01-31
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░ ░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Thomas Lynch

CompaniesPositionEnd
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Thomas Lynch's experience

Training of Thomas Lynch

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies21

Health Technology

Health Services

Health Technology

Consumer Services

Health Services

Commercial Services

Commercial Services

Health Services

Health Services

Health Services

Health Technology

Commercial Services

Commercial Services

Health Services

Consumer Services

The Schwartz Center for Compassionate Healthcare

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services